A robotic tray-loading system from ESS Technologies gently handles glass prefilled syringes.
Courtesy ESS Technologies.
ESS Technologies, an authorized system integrator for FANUC America, has designed a robotic tray-loading system that gently handles glass prefilled syringes. The high-speed pick-and-place system integrates three FANUC LR Mate 200iD robots with ESS-designed end-of-arm tooling (EOAT) to automate loading five-count thermoformed trays at a rate of up to 25 trays per minute.
The operator manually loads thermoformed trays into high-capacity tray magazines. Syringes enter the starwheel infeed via an infeed track that connects to the syringe-filling equipment at a rate of 125 syringes per minute. A starwheel picks syringes and lays them in carriers on the infeed conveyor. The first FANUC robot uses vacuum EOAT to pick a tray and, with the help of line tracking, places it on the lugged tray transport conveyor. A second robot, also equipped with line tracking, picks five syringes from the syringe infeed conveyor, loads three in the tray, and rotates the remaining two syringes 180-degrees before placing them to complete the tray. Any missed syringes fall into a soft discharge bin to be manually re-introduced into the robotic tray-loading cell.
Loaded trays convey to a tamping station that gently presses all five syringes into their locking cavities. At the discharge, a third FANUC robot uses a hybrid vacuum/gripper EOAT to rotate a tray and stack it on the tray that follows. The robot then picks both trays and places them on a discharge conveyor for downstream inspection and cartoning.
Source: ESS Technologies
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.